Minnetronix Medical’s Neuro division said today it joined with Duke University to co-found The Neurapheresis Consortium, which aims to accelerate the advancement of Neurapheresis Therapy intended to treat patients with diseases affecting the central nervous system.
The company’s Neurapheresis therapy system is a minimally invasive platform which includes a dual lumen catheter designed to be placed in the lumbar spine to filter contaminated cerebral spinal fluid to remove blood and blood breakdown byproducts, the St. Paul, Minn.-based company said. The system then returns clean cerebral spinal fluid to the patient.
Read the whole story on our sister site, Medical Design & Outsourcing
The post Minnetronix Neuro inks Neurapheresis Consortium deal with Duke appeared first on MassDevice.
from MassDevice https://ift.tt/2RERZAq
Cap comentari:
Publica un comentari a l'entrada